Scilex Holding Co (SCLXW) stock

SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.04−0.00 (-1.53%)

Close on Oct 30, 2026Market cap $17.50MP/E –Yield –

Scilex total assets

Total assets on the balance sheet at the end of each period.

Scilex's total assets was $253.56M at Jun 30, 2026. For fiscal 2025 it was $364.98M, up 292.7% from the year before. The highest annual figure on record is $364.98M in fiscal 2025.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$364.98M	+292.7%
FY2024	Dec 31, 2024	$92.95M	-8.2%
FY2023	Dec 31, 2023	$101.31M	+17.1%
FY2022	Dec 31, 2022	$86.53M	+11.0%
FY2021	Dec 31, 2021	$77.93M	+38966.8%
FY2020	Dec 31, 2020	$199.48K	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$253.56M	+202.7%
Q1 FY2026	Mar 31, 2026	$293.64M	+271.8%
Q4 FY2025	Dec 31, 2025	$364.98M	+292.7%
Q3 FY2025	Sep 30, 2025	$275.88M	+174.7%
Q2 FY2025	Jun 30, 2025	$83.76M	-19.9%
Q1 FY2025	Mar 31, 2025	$78.98M	-13.4%
Q4 FY2024	Dec 31, 2024	$92.95M	-8.2%
Q3 FY2024	Sep 30, 2024	$100.43M	+24.7%
Q2 FY2024	Jun 30, 2024	$104.54M	-17.3%
Q1 FY2024	Mar 31, 2024	$91.24M	+6.0%
Q4 FY2023	Dec 31, 2023	$101.31M	+17.1%
Q3 FY2023	Sep 30, 2023	$80.53M	-20.6%
Q2 FY2023	Jun 30, 2023	$126.46M	-11.1%
Q1 FY2023	Mar 31, 2023	$86.05M	-39.0%
Q4 FY2022	Dec 31, 2022	$86.53M	+11.0%
Q3 FY2022	Sep 30, 2022	$101.46M	-27.3%
Q2 FY2022	Jun 30, 2022	$142.30M	+1.7%
Q1 FY2022	Mar 31, 2022	$140.97M	+0.7%
Q4 FY2021	Dec 31, 2021	$77.93M	+38966.8%
Q3 FY2021	Sep 30, 2021	$139.64M	–
Q2 FY2021	Jun 30, 2021	$139.90M	–
Q1 FY2021	Mar 31, 2021	$140.06M	–
Q4 FY2020	Dec 31, 2020	$199.48K	–